Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
  • Press Releases
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
  • Press Releases
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > News > CDSCO Launches Digital Monitoring System on ONDLS to Track High-Risk Solvents

CDSCO Launches Digital Monitoring System on ONDLS to Track High-Risk Solvents

Published: October 25, 2025
SHARE

India’s drug regulator, CDSCO, has rolled out a real-time digital system on the ONDLS portal to monitor the supply and quality of high-risk solvents used in pharmaceutical manufacturing a move triggered by recent cough syrup contamination incidents.

Glimpse:

In response to fatal cases of syrup contamination, CDSCO has upgraded the Online National Drug Licensing System (ONDLS) to track high-risk solvents (like glycerin, propylene glycol, sorbitol, PEG, et al.). Manufacturers must now register, upload batch-level data and Certificates of Analysis (CoA), and submit vendor information giving regulators full visibility over production and distribution.

Amid growing alarm over cough syrups tainted with diethylene glycol (DEG), India’s Central Drugs Standard Control Organisation (CDSCO) has launched a digital monitoring system via the ONDLS portal to strengthen oversight of high-risk solvents used in pharmaceutical manufacturing

All state and union territory drug controllers have been instructed to ensure that manufacturers of pharmaceutical-grade solvents including glycerin, propylene glycol, maltitol, sorbitol, polyethylene glycol, and others obtain proper licensing via ONDLS. Existing licensees must register under the system’s “Old Licence Management” section and submit detailed records such as batch quantities, vendor information, and Certificates of Analysis (CoA).

Under the new mandate, no batch of these solvents can be released or distributed without proper registration, testing, and regulatory approval. The system enables real-time tracking of supply chains and quality assurance, closing loopholes in transparency and accountability across manufacturing and distribution.

This measure is part of CDSCO’s response to the shock caused by multiple child deaths in Madhya Pradesh, where contaminated cough syrup (notably “Coldrif”) was found to contain DEG far above permissible limits. The digital monitoring push reflects an urgency to prevent further pharmaceutical safety failures.

“We must ensure that the building blocks of medicines are beyond reproach this digital system gives us the eyes to detect, trace and prevent contamination.”

By

HB Team

Related News

SwishX Launches Agentic AI Platform for Pharma and MedTech, Secures $2.2 Million Seed Funding

May 13, 2026

Sanofi India and NHM Madhya Pradesh Join Forces to Expand Rare Disease & NCD Care

May 11, 2026

NIPER Raebareli Partners with Lofty Laboratories to Accelerate Pharma Innovation in India

May 11, 2026

Genient Partners with AIT Biotech to Accelerate Clinical Genomics Expansion

May 5, 2026

Metropolis Introduces Breakthrough Blood Test for Early Alzheimer’s Detection

April 29, 2026

Cohance Lifesciences Bets Big on Leadership with Umang Vohra at the Helm

April 27, 2026

₹2,000 Cr Push to Turn Uttar Pradesh into India’s Next Pharma Manufacturing Hub

April 27, 2026

Quadria Capital Eyes ₹4,500 Cr Bet on Samarth Lifesciences

April 27, 2026

NIPER Hajipur & Boehringer Ingelheim Join Forces to Fast Track Drug Innovation

April 27, 2026

Sun Pharma’s $13 Billion Bet: A Bold Move to Dominate Global Pharma

April 24, 2026

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

India–UK Biotech Corridor Launched to Power Next Wave of Life Sciences Innovation

April 23, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Eli Lilly Strikes $7B Deal to Supercharge Next Gen Cancer Therapies

April 22, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

Siemens Healthineers Explores Karnataka Partnership to Build Future Ready HealthTech Hubs

April 18, 2026

Eli Lilly Eyes Kelonia Buyout to Accelerate Next Gen Cancer Therapies

April 20, 2026
Kalyan Singh Super Specialty Cancer Institute Installs Uttar Pradesh’s First Government Digital PET-CT Scanner
Molbio Diagnostics Gets SEBI Green Light for ₹200 Cr IPO Boosting India’s Molecular Diagnostic Growth Story
Junction Teams Up with GRAIL to Simplify Access to Galleri Multi Cancer Blood Test via Digital Platforms
Sleep Smarter! Ultrahuman Home’s Major Upgrade Brings Smart Sleep Score, Snore & Respiratory Tracking to Bedrooms
CVS Completes Acquisition of 63 Former Rite Aid / Bartell Drug Stores, Absorbs 626 Prescription Files
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?